You have 9 free searches left this month | for more free features.

Thiazolidinediones

Showing 26 - 50 of 204

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Mexico (Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg), Glimepiride / Vildagliptin /

Not yet recruiting
  • Type 2 Diabetes
  • Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg)
  • Glimepiride / Vildagliptin / Metformin (4 mg/ 50 mg/ 1000 mg)
  • CancĂșn, Quintana Roo, Mexico
  • +4 more
Jun 8, 2021

Patients Infected With COVID-19 Trial in Granada (Vitamin D)

Unknown status
  • Patients Infected With COVID-19
  • Vitamin D
  • Granada, Andalucia, Spain
  • +1 more
Apr 3, 2020

s on Risk of Heart Failure Hospitalization and Amputation for

Completed
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Titusville, New Jersey
    Janssen Investigative Site
Aug 24, 2018

Hepatitis Trial in Kaohsiung City, Kaohsiung (Pioglitazone, )

Completed
  • Hepatitis
  • Kaohsiung City, Taiwan
  • +1 more
Jul 22, 2020

Type2 Diabetes Trial in Beijing (Glucophage 500Mg Tablet, Acarbose Tablets, Sitagliptin tablet)

Unknown status
  • Type2 Diabetes Mellitus
  • Glucophage 500Mg Tablet
  • +5 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 26, 2020

Huntington Disease Trial in Spain (Metformin, Placebo)

Recruiting
  • Huntington Disease
  • Elche, Alicante, Spain
  • +7 more
Mar 29, 2022

Sodium-glucose Cotransporter 2 Inhibitors Among Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
  • +3 more
  • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
  • +2 more
  • Montreal, Quebec, Canada
    Lady Davis Institute for Medical Research, Jewish General Hospit
Aug 17, 2020

Diabetes, Chronic Disease, Psychological Distress Trial in Chapel Hill (Immediate Chronic Disease Prevention Program (CDPP),

Recruiting
  • Diabetes
  • +2 more
  • Immediate Chronic Disease Prevention Program (CDPP)
  • +2 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Dec 9, 2022

Heart Failure, Diabetes Trial in Los Angeles (Metformin)

Completed
  • Heart Failure
  • Diabetes
  • Los Angeles, California
    Ahmanson-UCLA Cardiomyopathy Center
Aug 20, 2020

Diabetic Neuropathies Trial in Islamabad (SLP, SLP along with Physiotherapy, Physiotherapy)

Recruiting
  • Diabetic Neuropathies
  • SLP
  • +2 more
  • Islamabad, Federal, Pakistan
    Pakistan Railway Hospital
Mar 21, 2021

Type 2 Diabetes Trial in Canada, United States (Bexagliflozin, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • Canoga Park, California
  • +22 more
Jun 2, 2021

Polycystic Ovary Syndrome Trial in Shiraz (Cyproterone compound + Spironolactone, Metformin, Pioglitazone)

Completed
  • Polycystic Ovary Syndrome
  • Cyproterone compound + Spironolactone
  • +2 more
  • Shiraz, Fars, Iran, Islamic Republic of
    Shahid Motahhari Clinic, Shiraz University of Medical Sciences
Nov 8, 2019

Systemic Lupus Erythematosus Trial run by the NIAMS (PET/CT, Pioglitazone, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • PET/CT
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 23, 2021

Sodium-glucose Cotransporter 2 Inhibitors and Risk of

Completed
  • Type2 Diabetes
  • +5 more
  • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
  • Dipeptidyl peptidase-4 (DPP-4) inhibitors
  • Montreal, Quebec, Canada
    Lady Davis Institute for Medical Research, Jewish General Hospit
Oct 1, 2020

Diabetes, Type 2 Trial in Prague (Metformin Oral, Metformin local in AT, Exercise)

Completed
  • Diabetes Mellitus, Type 2
  • Metformin Oral
  • +2 more
  • Prague, Czechia
    Third Faculty of Medicine, Charles University
Feb 12, 2020

Squamous Cell Carcinoma of the Skin Trial (Pioglitazone)

Completed
  • Squamous Cell Carcinoma of the Skin
  • (no location specified)
Jun 2, 2020

T1DM Trial (Hyperbaric oxygen chamber (HBOC), sham Hyperbaric oxygen chamber (HBOC))

Not yet recruiting
  • T1DM
  • Hyperbaric oxygen chamber (HBOC)
  • sham Hyperbaric oxygen chamber (HBOC)
  • (no location specified)
Jun 1, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Fracture Risk With Thiazolidinediones

Completed
  • Fractures, Bone
  • Type II Diabetes
  • TZD only (RSG or PIO or troglitazone)
  • +2 more
  • (no location specified)
May 25, 2017

Insulin Resistance Trial (Metformin group, Rosiglitazone group, Placebo oral tablet)

Completed
  • Insulin Resistance
  • Metformin group
  • +2 more
  • (no location specified)
Oct 31, 2019

Obesity, Diabetes, Type 2 Trial in Oldenburg, Hamburg (Dapagliflozin 10mg, Exenatide 2 mg [Bydureon], Placebo Oral Tablet)

Terminated
  • Obesity
  • Diabetes Mellitus, Type 2
  • Dapagliflozin 10mg
  • +5 more
  • Oldenburg, Lower Saxony, Germany
  • +3 more
Mar 29, 2020

Diabetes, Type 2 Trial in Guadalajara (Exenatide LAR, Dulaglutide)

Unknown status
  • Diabetes Mellitus, Type 2
  • Guadalajara, Jalisco, Mexico
    Instituto de terapeutica Experimental y Clinica. Centro universi
Mar 24, 2020

Type 2 Diabetes Trial in Guangzhou (Complications assessment)

Unknown status
  • Type 2 Diabetes Mellitus
  • Complications assessment
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Apr 6, 2019

Type 2 Diabetes Trial in Korea, Republic of (vildagliptin, Pioglitazone)

Completed
  • Type 2 Diabetes
  • Busan, Korea, Republic of
  • +14 more
Dec 13, 2018

Diabetes, Pulmonary Tuberculosis Trial in Bandung, Lima, Bucharest (intensive monitoring)

Completed
  • Diabetes Mellitus
  • Pulmonary Tuberculosis
  • intensive monitoring
  • Bandung, West Java, Indonesia
  • +2 more
Apr 17, 2019